An economic analysis of the anti-adverse selection provisions in the Medical Schemes Act 131 of 1998

dc.contributor.authorGuiatheu Yogo, Georgia
dc.date.accessioned2022-09-20T08:54:31Z
dc.date.available2022-09-20T08:54:31Z
dc.date.issued2021
dc.descriptionA research report submitted to the School of Business Sciences, at the University of the Witwatersrand, in partial fulfilment of the requirements for the degree of Masters of Commerce (Insurance and Risk Management), 2021en_ZA
dc.description.abstractThe problems of adverse selection, asymmetry of information and moral hazard are well-known problems encountered in exchange markets. There are particularly well-recognized problems in the insurance market. To manage these problems in the insurance market, various measures have evolved in the Common Law such as recognizing the legal duty to disclose all material facts. Further insurance practice managesthese problems by inserting terms in insurance policies. These measures are discussed in the dissertation. In 1998, the Medical Scheme Act neutralized these measures when it introduced the community rating system and replaced these common law measures with statutory anti-adverse selection provisions such as late joiner penalty and waiting periods. Community rating prohibits the use of risk factors such as gender, age, and health status to determine the contribution to be paid by members and require all individuals to pay the same contribution irrespective of the difference in their risk profile. These are the very factors the common law requires the insured to disclose. The Medical Schemes Act thus creates a system vastly at odds with the common law position. Consequently, the reasons of government intervention in the health insurance market are examined by looking at the history of the legislation. Government intervention is discussed against the economic theory of competitive markets and market failure. Finally, the effectiveness of statutory anti-adverse selection provisions is discussed. This dissertation has two central conclusions, firstly the anti-adverse selection provisions affects the pricing mechanism and thus competitive efficiency of medical schemes. Secondly, these anti-adverse selection provisions are not the best way to solve and reduce the problems of adverse selection, asymmetry of information and moral hazard, they instead worsen the situation, and thus different measures should be proposed to achieve the policy objectives of the legislationen_ZA
dc.description.librarianCK2022en_ZA
dc.facultyFaculty of Commerce, Law and Managementen_ZA
dc.identifier.urihttps://hdl.handle.net/10539/33238
dc.language.isoenen_ZA
dc.schoolSchool of Business Sciencesen_ZA
dc.titleAn economic analysis of the anti-adverse selection provisions in the Medical Schemes Act 131 of 1998en_ZA
dc.typeThesisen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Buse8002A-masters dissertation-Guiatheu.pdf
Size:
1.71 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections